latest news releases from the newsroom
SunnComm International, Inc.
Viastar Records Picks SunnComm's MediaMax (Version 5) for Peter Cetera's New Release
PHOENIX, Nov. 18, 2004 (PRIMEZONE) -- SunnComm International, Inc. (Pink Sheets:SCMI) announced today that it has signed an agreement with Phoenix based Viastar Records, a division of Viastar Media Corporation (OTCBB:VISHE), for use of its MediaMax(tm) suite of copy management and enhancement technologies for Grammy Award winning recording artist Peter Cetera's "You Just Gotta Love Christmas". Cetera's holiday release will be the first commercial CD to benefit from the robust features available through SunnComm's newest technology, MediaMax Version 5.
Control Risks Group
Control Risks Group Publishes RiskMap to Forecast Opportunities and Trouble Spots for 2005
LONDON, Nov. 18, 2004 (PRIMEZONE) -- Control Risks Group, the international business risk consultancy, today launches RiskMap 2005, its annual study and forecast of political and security risks across the globe. Although the headlines in 2005 will continue to be dominated by the ongoing war on terror, the report argues that this may only serve to distract business from the more direct and critical challenges it will face around the world. While acknowledging the global security consequences of events in the Middle East, RiskMap 2005 contends that the greatest threat to corporate success in key investment destinations such as Russia, Nigeria, Venezuela and Indonesia will be longstanding and local risks.
Discovery Laboratories, Inc.
Discovery Labs Adds Two Senior Executives to Its Commercial Organization
DOYLESTOWN, Pa., Nov. 18, 2004 (PRIMEZONE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), today announced the appointment of two senior level commercial operations executives; Steven J. Gavel as Vice President of Sales and Thomas F. Miller, Ph.D., MBA, as Vice President of Marketing. Reporting directly to Mark G. Osterman, Discovery's Senior Vice President of Sales and Marketing, Mr. Gavel and Dr. Miller will be responsible for building a premier pulmonary sales and marketing organization including the management and execution of all related activities. Discovery will initially focus on the anticipated United States launch of its lead product Surfaxin(r) for the prevention of Respiratory Distress Syndrome (RDS) in premature infants. The FDA is presently reviewing Discovery's New Drug Application for clearance to market Surfaxin for RDS.
Celgene and Galapagos Enter Target Discovery Collaboration
WARREN, N.J. and MECHELEN, Belgium and LEIDEN, The Netherlands (PRIMEZONE) -- Celgene (Nasdaq:CELG), a leading global biopharmaceutical company with focus on the discovery, development and commercialization of innovative therapies for unmet medical needs in cancer and inflammatory disease, and Galapagos, Europe's leading target discovery and adenoviral services company, today announced that they have entered into a multi-year target discovery collaboration.Under the terms of the agreement, Galadeno (Galapagos' wholly owned services unit) will provide Celgene with its adenoviral siRNA and cDNA libraries, SilenceSelect(TM) and FLeXSelect(TM).
FTS Wireless, Inc.
FTS Lights another Air Rover Wi-Fi HotSpot
TAMPA, Fla., Nov. 18, 2004 (PRIMEZONE) -- FTS Wireless, Inc., a wholly owned subsidiary of FTS Group, Inc. (OTCBB:FLIP), an operator of retail wireless locations that market and sell next generation wireless and VoIP products, and services and operate Wi-Fi HotSpots today announced that its Brandon, Fl. retail wireless location is now an Air Rover Wi-Fi HotSpot.
Sunwin International Neutraceuticals, Inc.
Sunwin International Neutraceuticals, Inc. Announces 25% Increase in Sales of Chinese Sexual Enhancement Herbal Supplement
FORT LAUDERDALE, Fla., Nov. 18, 2004 (PRIMEZONE) -- Sunwin International Neutraceuticals, Inc. (OTCBB:SUWN), an industry leader in the distribution and manufacturing of Chinese herbs, veterinary medicines and low-calorie natural sweetener in China, announced today its sales of Chinese Herbal for sexual enhancement, which is called Epimedium or Horny Goat Weed, has increased 25% in the first six months of 2004 to 12.5 tons as compared to the same period in 2003. Epimedium is a Chinese herb which is a major component of natural sexual enhancement supplements. The company expects to produce 30 tons in 2004 and to increase to 50 tons in 2005.